PEPGEN INC. Prepaid Expense and Other Assets, Current
PEPGEN INC. (PEPG) had Prepaid Expense and Other Assets, Current of $3.09 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-06
- 2026-06-30: Prepaid Expense and Other Assets, Current $3.09M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $1.97M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $2.51M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $2.54M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.09M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.97M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $2.51M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $2.54M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $2.83M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $3.27M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $3.57M 10-K · filed 2026-03-04 | |
| 2024-09-30 | $3.51M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $3.47M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $2.40M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $2.27M 10-K · filed 2025-02-24 | |
| 2023-09-30 | $3.55M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $3.35M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $3.07M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $4.33M 10-K/A · filed 2024-03-29 | $4.27M 10-K · filed 2023-03-23 |
| 2022-09-30 | $4.58M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $3.43M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $2.24M 10-Q · filed 2022-06-16 | |
| 2021-12-31 | $2.35M 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |